IP Library Granted Patent US 10,028,688
Granted Patent B2
US 10,028,688 · App. 15/829,018 · Granted Jul 24, 2018

Systems and methods for parenterally procuring bodily-fluid samples with reduced contamination

Inventor: Richard G. Patton (Seattle, WA)
Assignee: Magnolia Medical Technologies, Inc.
A61B5/150221A61B5/150099A61B5/150251A61B5/150343A61B5/150977A61B5/150992B01L3/502B01L2200/026B01L2200/141B01L2300/0672B01L2400/082
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,028,688
App. No.
15/829,018
Granted
Jul 24, 2018
Kind
B2
Abstract

The present invention is directed to the parenteral procurement of bodily-fluid samples. The present invention is also directed to systems and methods for parenterally procuring bodily-fluid samples with reduced contamination from dermally-residing microbes. In some embodiments, a bodily-fluid withdrawing system is used to withdraw bodily fluid from a patient for incubation in culture media in one or more sample vessels. Prior to withdrawing bodily fluid into the one or more sample vessels for incubation, an initial volume of withdrawn bodily fluid is placed in one or more pre-sample reservoirs and is not used for the incubation in culture media.

Claims (53)

1. A method of using a sample procurement device to obtain a blood sample with reduced contamination from a patient, the method comprising:

establishing fluid communication with the vasculature of the patient and a first fluid flow path;

receiving an initial volume of blood from the patient;

in response to receiving the initial volume of blood from the patient, automatically sequestering the initial volume of blood in a reservoir integrated into the sample procurement device;

establishing fluid communication between the patient and a sample vessel, the sample vessel containing a culture media; and

receiving a second volume of blood into the sample vessel,

whereby sequestering the initial volume of blood sequesters contaminants present in the initial volume of blood, thereby reducing contamination in the blood received into the sample vessel.

2. The method of claim 1 , wherein the sample procurement device has a first state operable to allow sequestration of contaminants present in the initial volume of blood, and a second state operable to allow the second volume of blood to flow to a second fluid flow path, the sample procurement device configured to transition from the first state to the second state as a result of sequestering the initial volume of blood.

3. The method of claim 1 , wherein the initial volume of blood sequestered in the reservoir is not used for culture testing.

4. The method of claim 1 , wherein establishing fluid communication with the vasculature of the patient includes inserting a needle having a lumen into the vasculature of the patient.

5. The method of claim 1 , wherein the initial volume of blood sequestered in the reservoir is less than 5 ml.

6. The method of claim 1 , wherein the sample procurement device has a first state operable to allow the initial volume of blood to flow to the reservoir, and a second state operable to allow the second volume of blood to flow toward the sample vessel as a result of the initial volume of blood filling the reservoir.

7. The method of claim 1 , wherein the initial volume of blood is fluidically isolated in the reservoir.

8. A method of using a sample procurement device to obtain a blood sample with reduced contamination from a patient, the method comprising:

establishing fluid communication between the vasculature of the patient and a first fluid flow path;

receiving an initial volume of blood from the patient into a reservoir integrated into the sample procurement device;

as a result of filling the reservoir, diverting flow away from the reservoir thereby sequestering the initial volume of blood in the reservoir;

establishing fluid communication between the patient and a sample vessel; and

receiving a second volume of blood into the sample vessel,

whereby sequestering the initial volume of blood sequesters contaminants present in the initial volume of blood, thereby reducing contamination in the blood received into the sample vessel.

9. The method of claim 8 , wherein the initial volume of blood is less than 5 ml.

10. The method of claim 9 , wherein establishing fluid communication with the vasculature of the patient includes inserting a needle having a lumen into the vasculature of the patient, the initial volume of blood is greater than a volume of the lumen of the needle and less than 5 ml.

11. The method of claim 10 , wherein the needle is a first needle, the sample procurement device configured to be fluidically coupled to a second needle, the second needle being removably insertable into the sample vessel.

12. The method of claim 8 , wherein the sample procurement device further includes a diverter having a first state operable to allow sequestration of contaminants present in the initial volume of blood, and a second state operable to allow blood to flow toward the sample vessel.

13. The method of claim 8 , wherein the sample procurement device automatically sequesters the initial volume of blood in the reservoir and diverts flow away from the reservoir as a result of filling the reservoir.

14. The method of claim 8 , wherein the initial volume of blood is fluidically isolated in the reservoir.

15. The method of claim 8 , wherein the sample vessel contains a culture media.

16. The method of claim 8 , wherein the sample vessel is a syringe.

17. A method of using a sample procurement device to obtain a blood sample with reduced contamination from a patient, the method comprising:

establishing fluid communication between the vasculature of the patient and a first fluid flow path;

receiving an initial volume of blood from the patient;

sequestering the initial volume of blood in a reservoir integrated into the sample procurement device;

after blood stops flowing from the patient and the initial volume of blood is sequestered in the reservoir, establishing fluid communication between the needle and a sample vessel, the sample vessel containing a culture media; and

receiving a second volume of blood into the sample vessel,

whereby sequestering the initial volume of blood sequesters contaminants present in the initial volume of blood, thereby reducing contamination in the blood received into the sample vessel.

18. The method of claim 17 , wherein the initial volume of blood is less than 5 ml.

19. The method of claim 17 , wherein the sample procurement device further includes a diverter having a first state operable to allow sequestration of contaminants present in the initial volume of blood, and a second state operable to allow blood to flow toward the sample vessel.

20. The method of claim 19 , wherein the diverter automatically transitions from the first state to the second state as a result of filling the reservoir.

21. The method of claim 17 , wherein the initial volume of blood is fluidically isolated in the reservoir.

22. The method of claim 17 , wherein the sample vessel contains a culture media.

23. The method of claim 17 , wherein the sample vessel is a syringe.

24. A method of using a sample procurement device to obtain a blood sample with reduced contamination from a patient, the method comprising:

establishing fluid communication between the vasculature of the patient and an inlet of the sample procurement device;

receiving an initial volume of blood from the patient into a reservoir integrated into the sample procurement device;

in response to filling the reservoir, sequestering the initial volume of blood in the reservoir;

establishing fluid communication between the patient and a sample vessel, the sample vessel containing a culture media; and

receiving a second volume of blood into the sample vessel.

25. The method of claim 24 , wherein the sample procurement device has a first state operable to allow the initial volume of blood to flow to the reservoir, and a second state operable to allow the second volume of blood to flow toward the sample vessel as a result of the initial volume of blood filling the reservoir.

26. The method of claim 24 , wherein the initial volume of blood sequestered in the reservoir is not used for culture testing.

27. The method of claim 24 , wherein establishing fluid communication with the vasculature of the patient includes inserting a needle having a lumen into the vasculature of the patient.

28. The method of claim 24 , wherein the initial volume of blood sequestered in the reservoir is less than 5 ml.

29. The method of claim 24 , whereby sequestering the initial volume of blood sequesters contaminants present in the initial volume of blood, thereby reducing contamination in the blood received into the sample vessel.

30. The method of claim 24 , wherein the initial volume of blood is fluidically isolated in the reservoir.

Assignments (5)
PATENT SECURITY AGREEMENT Recorded Jan 2, 2024
From: MAGNOLIA MEDICAL TECHNOLOGIES, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 066178/0969 →
RELEASE OF SECURITY INTEREST Recorded Dec 14, 2021
From: FISH & RICHARDSON PC
To: MAGNOLIA MEDICAL TECHNOLOGIES, INC
Reel/Frame 058964/0845 →
LIEN Recorded Mar 30, 2021
From: MAGNOLIA MEDICAL TECHNOLOGIES, INC.
To: FISH & RICHARDSON P.C.
Reel/Frame 057204/0676 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2018
From: PATTON, RICHARD G.
To: MAGNOLIA MEDICAL TECHNOLOGIES, LLC
Reel/Frame 044922/0521 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2018
From: MAGNOLIA MEDICAL TECHNOLOGIES, LLC
To: MAGNOLIA MEDICAL TECHNOLOGIES, INC.
Reel/Frame 044922/0551 →
Continuity (13)
Continuation 15457082 · Mar 13, 2017
Continuation 15448891 · Mar 3, 2017
Continuation 15435684 · Feb 17, 2017
Continuation 15432310 · Feb 14, 2017
Continuation 15088842 · Apr 1, 2016
Continuation 14498102 · Sep 26, 2014
Continuation 14089267 · Nov 25, 2013
Continuation 13675295 · Nov 13, 2012
Continuation 13458508 · Apr 27, 2012
Division 13335241 · Dec 22, 2011
Continuation 11955635 · Dec 13, 2007
Provisional Application 60870599 · Dec 18, 2006
Related Publication 20180098723A1 · Apr 12, 2018
Cited By (13)
US 12,186,080 US 12,193,816 US 12,290,363 US 12,471,815 US 12,471,816 US 12,478,300 US 12,478,301 US 12,502,109 US 12,551,150 US 12,564,341 US 12,575,772 US 12,576,204 US 12,638,445